Kaneka Files Suit
2009-10-09
-
Kaneka Nutrients L.P.
Kaneka Nutrients L.P. (KNL) today announced that its parent company, Kaneka Corporation (Kaneka), has filed a lawsuit in Federal District Court in Los Angeles on October 6, 2009, accusing Sinochem Jiangsu Co. LTD. and Sinochem American Holdings Inc. of infringing Kaneka’s U.S. patent relating to reduced coenzyme Q10.
Reduced coenzyme Q10 (a.k.a. Ubiquinol), also known by its trade name KanekaQH™, is the active antioxidant form of the nutrient coenzyme Q10.
Kaneka has been the recognized industry leader in coenzyme Q10 for the past 30 years, and is the largest manufacturer of coenzyme Q10 in the world. KNL is the first and only manufacturer of coenzyme Q10 and reduced coenzyme Q10 in the United States.
|
|
|
Related Articles :
KanekaQ10(TM) to Be Used in Phase III Clinical Trial on Coenzyme Q10's Effects (2008-06-02)
The Huntington Study Group has launched a Phase III clinical trial, funded by the National Institute of Neurological Disorders and Stroke (part of the National Institutes of Health [NIH]), to determine the effect of the maximum effective dosage of Coenzyme
Q10 on cognitive function in individuals with Huntington’s Disease (HD). They will also examine the long-term safety of CoQ10.
Kaneka Actively Expanding New-Generation Coenzyme Q10 into Japan, US & Europe (2008-10-01)
Kaneka Corporation Announces Settlement (2009-09-22)
Kaneka Corporation has announced a settlement in a suit filed alleging infringement of U.S. Patent No. 7,145,044.
|
|
|
|